Shasun Pharmaceuticals Limited
Shasun Pharmaceuticals Limited, often referred to simply as Shasun, is a prominent player in the pharmaceutical industry, headquartered in India. Established in 1987, the company has made significant strides in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, catering to both domestic and international markets. With a strong presence in regions such as North America, Europe, and Asia, Shasun focuses on key therapeutic areas including anti-infectives, cardiovascular, and central nervous system disorders. The company is recognised for its commitment to quality and innovation, offering a diverse portfolio of products that stand out for their efficacy and safety. Shasun's dedication to research and development has positioned it as a trusted partner in the pharmaceutical sector, achieving notable milestones in regulatory approvals and collaborations. As a result, Shasun Pharmaceuticals Limited continues to enhance its market position, contributing to global health solutions.
DitchCarbon Score
How does Shasun Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shasun Pharmaceuticals Limited's score of 14 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shasun Pharmaceuticals Limited's reported carbon emissions
Shasun Pharmaceuticals Limited, headquartered in India, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprint. However, without specific information from Shasun Pharmaceuticals, it is unclear what initiatives or commitments they may have in place regarding carbon emissions and climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shasun Pharmaceuticals Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
